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Introduction
Congenital hyperthyroidism (CH) is a relatively com-
mon endocrine disease in children. CH is also one of the 
most classic diseases in newborn screening history, the 
incidence of which varied from 1:2000 to 1:4000 in dif-
ferent areas and different ethnicities.1-4 CH is caused by 
a dysfunction of the hypothalamus–pituitary–thyroid 
axis, which leads to a reduction of thyroxin secretion, 
which, in turn, causes severe damage to the brain. 
According to the clinical course of the disease, CH can 
be classified as either permanent or transient CH (PCH/
TCH). It was reported that the incidence of PCH was 
about 1:2000 to 1:3587 and that the incidence of TCH 
was about 1:1580 to 1:17 000.5,6 The major etiology of 
PCH was linked to dysgenesis, including complications 
such as athyreosis, atrophy, and ectopic, but the etiology 
of TCH was not that clear. Many studies suggested that 
the etiology of TCH was multiplicity, prematurity, low 
birth weight, and iodine deficiency or excessive use of 
antithyroid drugs. In addition, an interaction between 
genes and the environment may also be related to the 
occurrence of TCH.7-10
Up to now, there have been very few reports regard-
ing the incidence and etiology of PCH and TCH in 
China. Guangxi Province, which is located in the south-
west of China, is the largest minority nationality area for 
the Han and Zhuang nations. Its geography and ethnic 
makeup means that it is different from other areas of 
China. A previous study reported the incidence of CH as 
detected by NSP to be about 1:835 in Guangxi,11 which 
is much higher than the average for the whole country. 
But the incidence of confirmed cases of PCH and TCH 
among patients and the reasons of the high incidence of 
CH in this area are still unclear and is yet to be fully 
reported.
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Abstract
Background. A newborn screening program (NSP) for congenital hypothyroidism (CH) was carried out in Guangxi in 
order to understand the incidence of CH and the factors interrelated to major types of CH in this region of China. 
Methods. During 2009 to 2013, data from 930 612 newborns attending NSP in Guangxi were collected. Patients 
were classified with either permanent CH (PCH) or transient CH (TCH) after 2 years of progressive study. Results. 
A total of 1210 patients were confirmed with CH with an incidence of 1/769, including 68 PCH and 126 TCH cases 
with incidences of 1/6673 and 1/3385, respectively. The frequency of thyroid stimulating hormone values greater 
than 5 mIU/L was 7.2%, which, based on WHO guidelines, suggests that the population was mildly iodine deficient. 
Conclusions. The incidence of CH was high in Guangxi. Approximately two thirds of CH patients were TCH, which 
may be due to a deficiency in iodine within the population.
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The objective of this study was to confirm the high 
incidence of CH as detected by NSP and look at the 
interrelated factors linked to the major types of CH in 
Guangxi.
Methods
A total of 930 612 newborns (511 555 females and 
419 057 males) screened by the newborn screening pro-
gram (NSP) at Newborn Screening Center of Guangxi, 
China, from January 2009 to December 2013, were 
included in this study, and the screening rate was about 
93.1%.
Within 72 hours of birth, 3 drops of blood was taken 
from the heel of subjects and placed on a filter paper 
(S&S 903) for the measurement of thyroid stimulating 
hormone (TSH). TSH was measured by time-resolved 
fluorescence, Delfia method. The detection limit of the 
assay for TSH measurement was 8 mIU/mL. Patients 
with positive results at screening were recalled and a 
90% recall rate was achieved. Venous blood samples 
were collected from the positive patients for a confirma-
tion test by the chemiluminescence method. At this time 
serum blood TSH and free thyroxin (FT4) levels were 
also measured. After patients were confirmed to be posi-
tive for CH, it was still necessary to check the thyroid 
morphology by performing a thyroid ultrasound exami-
nation. For those patients where it was not possible to 
locate the thyroid by ultrasound, it was necessary to per-
form further scans using a radioisotope scanning 
technique.12
At the first diagnosis stage when recalled, patients 
were classified as CH, when their clinical profiles 
matched one of the following: (a) TSH ≥ 10 mIU/mL 
and FT4 < 12 pmol/L and (b) the thyroid imaging exam-
ination suggested athyreosis, atrophy, or ectopic. Other 
patients with elevated TSH continually, but normal FT4 
values and normal thyroid morphology, were classified 
as hyperthyroxinemia (some studies also classified these 
patients as suffering from subclinical hypothyroidism).13 
At the second diagnosis stage, after being followed-up 
for more than 2 years, patients were classified as PCH, 
when their clinical profiles matched the following: 
patients who were unable to stop treatment and therefore 
needed constant hormone replacement therapy. Those 
patients whose clinical profiles matched both of the fol-
lowing were classified as TCH: (a) the thyroid imaging 
examination indicated the location and morphology of 
the thyroid to be normal and (b) the thyroid remained 
functional for more than 6 months after treatment was 
stopped and the thyroid function test would continue to 
be performed monthly.
Data were analyzed using SPSS 13.0, and the rela-
tionship between the multiplicity of factors and the 
results of the second diagnosis were analyzed with mul-
tiple logistic regression analysis.
Results
A total of 1210 patients (659 males and 551 females) 
were confirmed as potential CH cases among 930 612 
newborns. Of these 559 were diagnosed with CH and 
651 with hyperthyroxinemia. The incidence of CH and 
hyperthyroxinemia was 60.0/100 000 (1/1665) and 
69.9/100 000 (1/1430), respectively, with the total being 
120.0/100 000 (1/769). In the 1210 confirmed patients, 
391 patients (32.2% of the total including 331 hyperthy-
roxinemia patients and 60 patients with congenital 
hypothyroidism) were lost to follow-up, and thus 819 
patients took part in the study. From December 2009 to 
December 2013, 273 patients were followed-up for 
more than 2 years, and 68 patients were diagnosed with 
PCH, 126 patients were diagnosed with TCH, and 78 
patients were still under review (Figure 1). Based on 
screening of the population at the present time, the inci-
dence of PCH was 15/100 000 (1/6673), the incidence of 
TCH was 29.5/100 000 (1/3385), and the ratio of PCH to 
TCH is approximately 1:2.
In 194 patients (68 with PCH and 126 with TCH) with 
clear diagnosis of the disease, multiple logistic regression 
analysis was performed. The final diagnosis was consid-
ered as the dependent variable (PCH/TCH, 0/1), and the 
gender, gestational age, birth weight, and TSH and FT4 
values at screening and diagnosis were considered as 
independent variables. The results indicate that TSH val-
ues at screening and diagnosis were correlated with TCH. 
However, gender, gestational age, and birth weight were 
not the independent risk factors for TCH (Table 1). The 
area under the ROC curve (AUC) of TSH values at 
screening and diagnosis were 0.78 and 0.73 and the P val-
ues were 1.16 × 10−6 and 1.08 × 10−7, receptively.
To further analyze the reasons for the high incidence 
of CH, the TSH values of 930 612 newborns were clas-
sified following the guidelines for iodine deficiency as 
denoted by the World Health Organization. The results 
show that the TSH values of 7.2% newborns (67 208 out 
of 930 612 newborns) were above 5 mIU/mL (Table 2).
Discussion
The NSP has been developed in Guangxi since 1996, but 
in the early years of implementation the screening rate 
was lower than 10%. From 2009, when the government 
actively promoted the NSP in the whole province, the 
screening rate increased to 93.1%. The newborn screen-
ing laboratory of Guangxi accounts for around 50% of 
the newborns in Guangxi each year. Hence, data in this 
study are representative of the general population.
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The overall incidence of the disease was 1/769, with 
the incidence for CH and hyperthyroxinemia being 
1/1665 and 1/1430, respectively. The overall incidence 
of the disease was much higher than previous reports. In 
the cities of Beijing, Shanghai, and Zhejiang, the inci-
dence of CH was reported as 1/2034,14 1/2050,1 and 
1/1618,15 respectively, and the incidence of the whole 
country was found to be approximately 1/2000.1 In this 
study, for patients with a final diagnosis made at the sec-
ond diagnosis stage, the ratio of PCH to TCH was about 
1:2, with TCH being in the majority, and this was also 
different from other reports,16,17 and indicated that the 
Figure 1. Distribution of permanent and transient CH in 273 patients followed-up for more than 2 years.
Table 1. Multiple Logistic Regression Analysis of Transient CH.
Estimate Wald χ2 Pa AUC
Diagnosis TSH 0.02 23.64 1.16 × 10−6 0.73
Screening TSH(log) 1.02 28.23 1.08 × 10−7 0.78
Abbreviations: CH, congenital hypothyroidism; AUC, area under the curve; TSH, thyroid stimulating hormone.
aP < .05 was considered statistical significant.
Table 2. The Frequency of TSH Values Greater Than 5 mIU/L in Newborns From 2009 to 2013.
Year Population Screened (n) Number of TSH > 5 mIU/mL (n) Proportion of TSH > 5 mIU/mL (%)
2009 58 135 4716 8.11%
2010 154 072 10 241 6.65%
2011 214 839 12 749 5.93%
2012 241 565 20 938 8.67%
2013 262 001 18 564 7.08%
Total 930 612 67 208 7.22%
Abbreviation: TSH, thyroid stimulating hormone.
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higher incidence of CH in Guangxi is mainly due to 
increased TCH.
The etiology of TCH is complex, with several factors 
correlating to the disease including prematurity, low 
birth weight, intake of iodine, as well as genetic fac-
tors.18,19 Based on the available data of gender, gesta-
tional age, birth weight, and TSH and FT4 values, the 
cause of the high incidence of CH was investigated by 
multivariate logistic regression analysis. The results 
indicate that TSH values were related to TCH, and gen-
der, gestational age, and birth weight were not indepen-
dent risk factors for TCH.
For further analyses, the guidelines for determination 
of iodine deficiency as laid down by the World Health 
Organization were considered. The World Health 
Organization guidelines are based on neonatal TSH val-
ues of above 5 mIU/L of whole blood and a frequency of 
less than 3% of the population is considered iodine defi-
cient. Frequencies of 3% to 19.9% indicate mild iodine 
deficiency disorders, frequencies of 20% to 39.9% and 
above 40% indicate moderate and severe iodine defi-
ciency disorders, respectively. In 930 612 newborns, the 
frequency of neonatal TSH above 5 mIU/L was about 
7.2% and this indicated there was mild iodine deficiency 
in the population in Guangxi.20 Iodine is distributed all 
over the natural world, especially in the soil and water, 
but unfortunately it is not evenly distributed. The con-
tent of iodine in the soil of mountain areas tends to be 
the lowest with the highest levels found on the plains. 
The landscape of Guangxi is made up of karst land-
forms, with the surface of the earth being rough and with 
a poor soil quality. Both these conditions discourage the 
storage of iodine in the soil and therefore the water and 
crops inevitably possess low iodine content in compari-
son with other regions. People living in this type of envi-
ronment are bound to suffer from iodine deficiency. Our 
data would strongly suggest that the iodine deficiency 
may well be related to the high prevalence of TCH in 
Guangxi.
Conclusions
The overall incidence of CH in Guangxi was relatively 
high in comparison to other areas of China. Among 
those patients, the majority had TCH and this may be 
related to iodine deficiency in the population. Future 
work should focus on determination of urinary iodine in 
the local population in order to clarify these findings. It 
would also be useful to explore whether the geographic 
and ethnic makeup of the Guangxi region of China con-
tribute to presence of TCH in population by determining 
whether gene mutations are contributing factors. It is 
important to determine the etiology of the disease so that 
preventative strategies can be implemented to improve 
health care within these communities.
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